FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time Bid/Ask 04:26:27 2024-05-23 EDT | ||
| 11.27 EUR / 11.47 EUR | +0.35% |
|
| Current month | +4.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 11.33 | -5.50% |
| 24-05-21 | 11.99 | -3.85% |
| 24-05-20 | 12.47 | +1.30% |
| 24-05-17 | 12.31 | +6.49% |
| 24-05-16 | 11.56 | +5.86% |
Delayed Quote Börse Stuttgart
Last update May 22, 2024 at 03:53 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG32UV |
| ISIN | DE000MG32UV4 |
| Date issued | 2024-04-26 |
| Strike | 114.7 $ |
| Maturity | Unlimited |
| Parity | 2.22 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.76 € |
|---|---|
| Lowest since issue | 9.25 € |
| Spread | 0.2 € |
| Spread % | 1.73% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.9
USD
Average target price
146.8
USD
Spread / Average Target
+3.48%
- Stock Market
- Certificates
- Certificat
